XML 79 R68.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation (Stock Based Compensation Activity) (Detail) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Document Period End Date Mar. 31, 2018    
Number of Options, Balance 106   273
Options outstanding, intrinsic value $ 5   $ 10
Stock Issued During Period, Value, Restricted Stock Award, Gross 13 $ 19  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized $ 48    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 10 months   1 year 8 months
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Weighted Average Remaining Contractual Term 1 year 7 months    
Performance-Based and Market-Based RSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms 1 year 10 months    
Weighted Average Grant Price, Balance $ 33.06    
Weighted Average Grant Price, Granted at fair market value 48.72    
Weighted Average Grant Price, Vested/exercised 0.00    
Weighted Average Grant Price, Canceled 54.00    
Weighted Average Grant Price, Balance $ 35.20   $ 33.06
Number of RSUs, Balance 994    
Number of RSUs, Granted at fair market value 349    
Number of RSUs, Vested/exercised 0    
Number of RSUs, Canceled (138)    
Number of RSUs, Balance 1,205   994
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $ 56    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Number of Shares Outstanding 269    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Weighted Average Grant Date Fair Value $ 44.47    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Weighted Average Remaining Contractual Term 2 years 7 months    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Expected to Vest $ 13    
Restricted Stock Units (RSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted Average Grant Price, Balance $ 34.54    
Weighted Average Grant Price, Granted at fair market value 48.66 $ 34.41  
Weighted Average Grant Price, Vested/exercised 35.20    
Weighted Average Grant Price, Canceled $ 33.12    
Weighted Average Grant Price, Balance     $ 34.54
Number of RSUs, Balance 1,160    
Number of RSUs, Granted at fair market value 317    
Number of RSUs, Vested/exercised (357)    
Number of RSUs, Canceled (28)    
Number of RSUs, Balance     1,160
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Number of Shares Outstanding 1,092    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Weighted Average Grant Date Fair Value $ 38.45    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Weighted Average Remaining Contractual Term 1 year 4 months    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Expected to Vest $ 51